Smart antioxidant-containing polymer responds to body chemistry, environment

Oxidants found within living organisms are byproducts of metabolism and are essential to wound-healing and immunity. However, when their concentrations become too high, inflammation and tissue damage can occur. University of Illinois engineers have developed and tested a new drug-delivery system that senses high oxidant levels and responds by administering just the right amount of… Read More »

Catalent reportedly to buy Paragon Bioservices for $1.2 billion

Catalent said on Monday it would buy privately held gene therapy-focused Paragon Bioservices in an all-cash deal for $ 1.2 billion, helping the drug developer expand its capabilities to make specialized and costly treatments. Paragon, backed by private-equity firms Camden Partners and NewSpring Capital, focuses on developing and manufacturing products such as complex biopharmaceuticals for… Read More »